# LifeTech Scientific, ABG Innovation and Quantum Surgical form JV for surgical robot in China

LifeTech Scientific (Shenzhen) Co., Ltd., ABG Innovation-Quantum Limited and Quantum Surgical SAS signed a strategic cooperation agreement on April 2, 2019 to establish a joint venture in Guangdong, China, to develop and commercialize an interventional oncology integrated robotic platform for liver cancer treatment.

- Type: Partnership
- Announced: 2019-04-02
- Where: Guangdong, China, China
- Status: announced
- Products: interventional oncology integrated robotic platform
- Sectors: [Automation and Robotics](https://endata.com/sectors/automation-robotics.md), [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [LifeTech Scientific](https://endata.com/companies/38475.md)
- [LifeTech Scientific](https://endata.com/companies/38475.md) (partner)
- [ABG Innovation-Quantum Limited](https://endata.com/companies/38476.md) (partner)
- [Quantum Surgical SAS](https://endata.com/companies/38477.md) (partner)
- [Ally Bridge Group](https://endata.com/companies/38513.md) (partner)

## Sources

- [beta.zhitongcaijing.com](http://beta.zhitongcaijing.com/content/detail/195071.html), 2019-04-03: "三方将在中国广东成立一家合营企业，以推动指定产品(包含肿瘤介入集成机器人平台及其升级版本)在中国的研发和商业化"
- [biospace.com](https://www.biospace.com/ally-bridge-lifetech-scientific-and-quantum-surgical-announce-three-way-china-joint-venture-to-develop-innovative-surgical-robot-for-the-treatment-of-liver-cancer), 2019-04-04: "The JV will focus on the R&D and commercialization of Quantum Surgical's integrated surgical robot platform in China for interventional oncology with the first target indication being liver cancer."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.